We also observed a network of female-biased genes enriched on estrogenic, progestogenic, androgenic, and aromatase inhibitor drugs, corroborating these genes interact with sex hormone biology in women, yet the use of estrogen therapies for AD in women remains uncertain2,15. This evidence concerns the gene PLXNA3 and Alzheimer disease.